These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2575262)

  • 1. Striatal D2 dopaminergic receptor status ascertained in vivo by positron emission tomography and 76Br-bromospiperone in untreated schizophrenics.
    Martinot JL; Huret JD; Peron-Magnan P; Mazoyer BM; Baron JC; Caillard V; Syrota A; Loo H
    Psychiatry Res; 1989 Sep; 29(3):357-8. PubMed ID: 2575262
    [No Abstract]   [Full Text] [Related]  

  • 2. The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride.
    Martinot JL; Paillère-Martinot ML; Loc'h C; Hardy P; Poirier MF; Mazoyer B; Beaufils B; Mazière B; Allilaire JF; Syrota A
    Br J Psychiatry; 1991 Mar; 158():346-50. PubMed ID: 1827999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.
    Martinot JL; Peron-Magnan P; Huret JD; Mazoyer B; Baron JC; Boulenger JP; Loc'h C; Maziere B; Caillard V; Loo H
    Am J Psychiatry; 1990 Jan; 147(1):44-50. PubMed ID: 2293788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.
    Hietala J; Syvälahti E; Vuorio K; Någren K; Lehikoinen P; Ruotsalainen U; Räkköläinen V; Lehtinen V; Wegelius U
    Arch Gen Psychiatry; 1994 Feb; 51(2):116-23. PubMed ID: 7905257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo quantitative imaging of dopamine receptors in human brain using positron emission tomography and [76Br]bromospiperone.
    Mazière B; Loc'h C; Baron JC; Sgouropoulos P; Duquesnoy N; D'Antona R; Cambon H
    Eur J Pharmacol; 1985 Aug; 114(3):267-72. PubMed ID: 3877639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of 77Br-spiperone in the striata of schizophrenic patients and controls.
    Crawley JC; Crow TJ; Johnstone EC; Oldland SR; Owen F; Owens DG; Smith T; Veall N; Zanelli GD
    Nucl Med Commun; 1986 Aug; 7(8):599-607. PubMed ID: 2946010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone.
    Tune LE; Wong DF; Pearlson G; Strauss M; Young T; Shaya EK; Dannals RF; Wilson AA; Ravert HT; Sapp J
    Psychiatry Res; 1993 Dec; 49(3):219-37. PubMed ID: 7909948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients.
    Coppens HJ; Slooff CJ; Paans AM; Wiegman T; Vaalburg W; Korf J
    Biol Psychiatry; 1991 Apr; 29(7):629-34. PubMed ID: 1675892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal dopamine D2 receptors in tardive dyskinesia: PET study.
    Blin J; Baron JC; Cambon H; Bonnet AM; Dubois B; Loc'h C; Mazière B; Agid Y
    J Neurol Neurosurg Psychiatry; 1989 Nov; 52(11):1248-52. PubMed ID: 2574230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy.
    Baron JC; Mazière B; Loc'h C; Cambon H; Sgouropoulos P; Bonnet AM; Agid Y
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):131-6. PubMed ID: 3485639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central D2 receptors and negative symptoms of schizophrenia.
    Martinot JL; Paillère-Martinot ML; Loc'h C; Lecrubier Y; Dao-Castellana MH; Aubin F; Allilaire JF; Mazoyer B; Mazière B; Syrota A
    Br J Psychiatry; 1994 Jan; 164(1):27-34. PubMed ID: 8137107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients.
    Nordström AL; Nyberg S; Olsson H; Farde L
    Arch Gen Psychiatry; 1998 Mar; 55(3):283-4. PubMed ID: 9510228
    [No Abstract]   [Full Text] [Related]  

  • 13. "In vivo" visualization by positron emission tomography of the progressive striatal dopamine receptor damage occurring in MPTP-intoxicated non-human primates.
    Hantraye P; Loc'h C; Tacke U; Riche D; Stulzaft O; Doudet D; Guibert B; Naquet R; Mazière B; Mazière M
    Life Sci; 1986 Oct; 39(15):1375-82. PubMed ID: 3489875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Typical antipsychotic drugs -- D(2) receptor occupancy and depressive symptoms in schizophrenia.
    Bressan RA; Costa DC; Jones HM; Ell PJ; Pilowsky LS
    Schizophr Res; 2002 Jul; 56(1-2):31-6. PubMed ID: 12084417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single photon emission tomography assessment of cerebral dopamine D2 receptor blockade in schizophrenia.
    Geaney DP; Ellis PM; Soper N; Shepstone BJ; Cowen PJ
    Biol Psychiatry; 1992 Aug; 32(3):293-5. PubMed ID: 1358229
    [No Abstract]   [Full Text] [Related]  

  • 16. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.
    Nordström AL; Farde L; Eriksson L; Halldin C
    Psychiatry Res; 1995 Aug; 61(2):67-83. PubMed ID: 7480390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study.
    Pilowsky LS; Costa DC; Ell PJ; Verhoeff NP; Murray RM; Kerwin RW
    Br J Psychiatry; 1994 Jan; 164(1):16-26. PubMed ID: 8137105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodoethylspiperone, a new potential agent for exploration of central dopamine D2 receptors: synthesis and preliminary in vivo study.
    Chalon S; Frangin Y; Guilloteau D; Caillet M; Guimbal C; Schmitt MH; Desplanches G; Baulieu JL; Besnard JC
    Int J Rad Appl Instrum B; 1990; 17(4):389-95. PubMed ID: 2143754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo assay for neuroleptic receptor binding in the striatum. Positron tomography in humans.
    Cambon H; Baron JC; Boulenger JP; Loc'h C; Zarifian E; Maziere B
    Br J Psychiatry; 1987 Dec; 151():824-30. PubMed ID: 2901886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
    Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L
    Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.